In biotech, observes Vir Biotechnology president and CEO George Scangos, it’s especially crucial to fully understand the market, and the means by which a new therapy will be purchased, prescribed and distributed. Many scientifically successful drugs, he points out, have been commercial failures—further demonstrating the importance of making sure the market is prepared to accept (and pay for) a new therapy.
Related
Josh Wolfe,
Lux Capital
Investing at the Cutting Edge [Entire Talk]
The entrepreneurs that attract venture capital investments think differently and tackle big problems that few others are willing to
Josh Wolfe,
Lux Capital
Investing at the Cutting Edge [Entire Talk]
The entrepreneurs that attract venture capital investments think differently and tackle big problems that few others are willing to
Rahul Roy-Chowdhury,
Grammarly
Responsible AI Innovation [Entire Talk]
AI tools are the future of technology. People have the power to ensure AI benefits us.
Rahul Roy-Chowdhury,
Grammarly
Responsible AI Innovation [Entire Talk]
AI tools are the future of technology. People have the power to ensure AI benefits us.
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
